Oncolytics Biotech (ONCY) Other Non-Current Liabilities (2009 - 2025)
Oncolytics Biotech's Other Non-Current Liabilities came in at $123,528 for Q3 2025, up 7.3% from $115,089 a year earlier but down 82.6% from the prior quarter.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Other Non-Current Liabilities (2009 - 2025) Analysis & Trends
At the end of FY2024, Oncolytics Biotech's Other Non-Current Liabilities was $1.18 million, up 380.3% from FY2023.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of 13.1% (FY2019 to FY2024).
- Going back by year, Other Non-Current Liabilities was $246,067 in FY2023, $280,880 in FY2021 (+203.5%) and $92,552 in FY2020 (-85.5%).
- The five-year range for quarterly Other Non-Current Liabilities is $24,594 (Q2 2022) to $2.94 million (Q2 2021).
- Year-over-year, Other Non-Current Liabilities increased in six of the last seven quarters, with growth averaging 249.7%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2024 (growth of 708.2%), and the weakest in Q2 2022 (a decline of 99.2%).
- Business Quant data shows ONCY's Other Non-Current Liabilities at $708,722 (Q2 2025), $369,366 (Q1 2025) and $1.16 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Oncolytics Biotech | 60.94 Mn | 32.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 748,461.43 |
| Mar 31, 2025 | 852,604.32 |
| Dec 31, 2024 | 682,936.31 |
| Sep 30, 2024 | 808,361.97 |
| Jun 30, 2024 | 619,009.74 |
| Mar 31, 2024 | 460,254.12 |
| Sep 30, 2023 | 3.85 Mn |
| Jun 30, 2023 | 115,471.69 |
| Mar 31, 2023 | 35,497.97 |
| Sep 30, 2022 | 36,586.35 |
| Jun 30, 2022 | 24,338.49 |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 2.84 Mn |
| Sep 30, 2021 | 2.84 Mn |
| Jun 30, 2021 | 2.92 Mn |
| Mar 31, 2021 | 2.87 Mn |
| Dec 31, 2020 | 2.84 Mn |
| Sep 30, 2020 | 3.62 Mn |
| Jun 30, 2020 | 3.62 Mn |
| Mar 31, 2020 | 3.62 Mn |
API Access
Oncolytics Biotech Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();